Bull
$6.77
Scenario price
$12.340
-0.292 (-2.37%)At close
Aveanna Healthcare Holdings Inc. is a provider of diversified home care platforms. The Company's segments include Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment includes private duty nursing (PDN) services, as well as pediatric therapy services. The HHH segment includes home health services, as well as hospice and specialty program services. Its home health services involve the provision of in-home services to its patients by its clinicians, which include nurses, therapists, social workers and home health aides. Its hospice services involve a supportive philosophy and concept of care for those nearing the end of life. The Medical Solutions segment offers a line of enteral nutrition supplies and other products to adults and children, delivered on a periodic or as-needed basis. The MS business serves patients who have short or long-term disabilities and require a supply of infant, pediatric and adult formulas.
Aveanna Healthcare is currently priced at $12.34, which is below the average analyst price target of $15, indicating potential upside. However, the RSI is at 45.375, suggesting that the stock is neither overbought nor oversold, and the recent insider selling has increased by 675.38%, which raises concerns about potential short-term volatility. Therefore, it may be prudent to hold off on buying at this time until more favorable conditions arise.
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Jim Cramer's Insights on Multiple Stocks

Biotech Stocks Reach New 52-Week Highs

Biotech Stocks Reach 52-Week Highs Driven by Clinical and Financial Progress

Aveanna Healthcare to Attend Deutsche Bank Summit

Aveanna Healthcare Prices Secondary Offering of 15 Million Shares
Aveanna Healthcare Holdings Inc. is a provider of diversified home care platforms. The Company's segments include Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment includes private duty nursing (PDN) services, as well as pediatric therapy services. The HHH segment includes home health services, as well as hospice and specialty program services. Its home health services involve the provision of in-home services to its patients by its clinicians, which include nurses, therapists, social workers and home health aides. Its hospice services involve a supportive philosophy and concept of care for those nearing the end of life. The Medical Solutions segment offers a line of enteral nutrition supplies and other products to adults and children, delivered on a periodic or as-needed basis. The MS business serves patients who have short or long-term disabilities and require a supply of infant, pediatric and adult formulas. It operates in the Healthcare sector (SERVICES-HOME HEALTH CARE SERVICES industry).
Aveanna Healthcare is currently priced at $12.34, which is below the average analyst price target of $15, indicating potential upside. However, the RSI is at 45.375, suggesting that the stock is neither overbought nor oversold, and the recent insider selling has increased by 675.38%, which raises concerns about potential short-term volatility. Therefore, it may be prudent to hold off on buying at this time until more favorable conditions arise.
No posts yet
Sign up or log in to join the discussionThis page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.